000
| 01282nam 2200253za 4500 |
---|
001 | 9.629954 |
---|
003 | CaOODSP |
---|
005 | 20221107134256 |
---|
007 | cr ||||||||||| |
---|
008 | 150407s2015||||xxc|||||o f|0| 0 eng d |
---|
020 | |a978-1-100-25790-7 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aHP40-135/2015E-PDF |
---|
110 | 2 |aPublic Health Agency of Canada. |
---|
245 | 10|aRe-immunization with polysaccharide 23-valent pneumococcal vaccine (Pneu-P-23) |h[electronic resource] |
---|
246 | 1 |iAt head of title: |aAdvisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI) |
---|
260 | |aOttawa : |bPublic Health Agency of Canada, |cApril 2015. |
---|
300 | |a28 p. : |btables. |
---|
500 | |aAlso available in French under title: Une déclaration d’un comité consultatif (DCC), Comité consultatif national de l’immunisation (CCNI) : revaccination avec le vaccin polysaccharidique 23-valent contre le pneumocoque (Pneu-P-23). |
---|
504 | |aIncludes bibliographical references. |
---|
690 | 07|aImmunization|2gcpds |
---|
775 | 08|tRevaccination avec le vaccin polysaccharidique 23-valent contre le pneumocoque (Pneu-P-23)|w(CaOODSP)9.677547 |
---|
856 | 40|qPDF|s1.13 MB|uhttps://publications.gc.ca/collections/collection_2015/aspc-phac/HP40-135-2015-eng.pdf |
---|